Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
147
datasets available to search
ShareScore release 0.9.0
Dataset results
147 results for “vildagliptin”
Safety and Efficacy of Vildagliptin Plus Metformin (SPC) Treatment in Type 2 Diabetes Mellitus Patients
ClinicalTrials.gov study NCT01582243. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HK-2 cell cultured with normal glucose, high glucose, dapagliflozin, metformin and vildagliptin
GEO Series GSE179226. Homo sapiens. 15 samples. Type: Non-coding RNA profiling by array.
Figure 4 from: Mohamed AA, Hamed HE, Rahi FA (2024) Formulation, characterization and evaluation of vildagliptin and metformin combined tablets. Pharmacia 71: 1-6. https://doi.org/10.3897/pharmacia.71.e117712
Figure 4 Release of MET from tablets.
Figure 3 from: Mohamed AA, Hamed HE, Rahi FA (2024) Formulation, characterization and evaluation of vildagliptin and metformin combined tablets. Pharmacia 71: 1-6. https://doi.org/10.3897/pharmacia.71.e117712
Figure 3 VD Calibration curve.
Figure 2 from: Mohamed AA, Hamed HE, Rahi FA (2024) Formulation, characterization and evaluation of vildagliptin and metformin combined tablets. Pharmacia 71: 1-6. https://doi.org/10.3897/pharmacia.71.e117712
Figure 2 MET Calibration curve.
Figure 5 from: Mohamed AA, Hamed HE, Rahi FA (2024) Formulation, characterization and evaluation of vildagliptin and metformin combined tablets. Pharmacia 71: 1-6. https://doi.org/10.3897/pharmacia.71.e117712
Figure 5 Release of VD from tablets.
Bioequivalence Study to Compare Metformin / Vildagliptin Versus Galvumet®
ClinicalTrials.gov study NCT06073600. IPD Sharing: NO. Countries: 1. Publications: 0.
Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00975065. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Bioequivalence Study of Fixed-dose Combination of Vildagliptin and Metformin HCI 50/1000 mg FCT Under Fed Conditions
ClinicalTrials.gov study NCT06244407. IPD Sharing: NO. Countries: 0. Publications: 0.
To Compare the Efficacy and Safey of Vildagliptin Compared to Voglibose in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00368134. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Does Vildagliptin Affect Portal Vein Pressure In Patients With Type 2 Diabetes Mellitus? A Cross Sectional Study
ClinicalTrials.gov study NCT01963130. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion in Uncontrolled Type 2 Diabetes
ClinicalTrials.gov study NCT03563794. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00383578. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Bioequivalence Study to Compare Metformin / Vildagliptin (850 mg/50 mg) Versus Galvumet®
ClinicalTrials.gov study NCT06103747. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetics of Vildagliptin in Mild, Moderate and Severe Renal Impaired Patients
ClinicalTrials.gov study NCT00818571. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5
ClinicalTrials.gov study NCT00728351. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy
ClinicalTrials.gov study NCT01565096. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency
ClinicalTrials.gov study NCT00646542. IPD Sharing: Not stated. Countries: 12. Publications: 0.
Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment
ClinicalTrials.gov study NCT00567047. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study To Compare the Effect of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00351832. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.